logo
How Is Seagate Technology's Stock Performance Compared to Other Tech Stocks?

How Is Seagate Technology's Stock Performance Compared to Other Tech Stocks?

Yahoo5 hours ago

Singapore-based Seagate Technology Holdings plc (STX) engages in the provision of data storage technology and infrastructure solutions in Singapore, the U.S., and internationally. With a market cap of $27.8 billion, Seagate operates as one of the largest manufacturers of hard disk drives (HDDs) in the world.
Companies with a market cap of $10 billion or more are categorized as "large-cap stocks." Seagate fits this description perfectly, with its market cap exceeding this threshold, reflecting its substantial size and influence in the SSD and HDD storage market.
Is Palantir Stock Poised to Surge Amidst the Israel-Iran Conflict?
CoreWeave Stock Is Too 'Expensive' According to Analysts. Should You Sell CRWV Now?
'It Has No Utility': Warren Buffett Doesn't Care How High Gold Goes, He Isn't a Buyer
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else.
Seagate touched its all-time high of $133.76 in yesterday's trading session before slightly pulling back. STX stock has soared 48.1% over the past three months, significantly outpacing the Technology Select Sector SPDR Fund's (XLK) 13.9% gains during the same time frame.
STX has outpaced the tech sector over the longer term as well. STX stock has surged 52.1% on a YTD basis and 23.9% over the past 52 weeks, outperforming XLK's 3.9% uptick in 2025 and 4.4% gains over the past year.
Seagate's stock has shot up above its 50-day moving average in late April and above its 200-day moving average in May, underscoring its bullish upturn.
Seagate Technology's stock prices rallied 11.6% in the trading session after the release of its impressive Q3 results on Apr. 29. During the quarter, demand for mass capacity storage remained elevated, leading to Seagate's topline soaring 30.5% year-over-year to $2.2 billion, beating the Street's expectations by 1.3%. Moreover, the company experienced a massive improvement in its margins. Seagate's adjusted operating margin for the quarter jumped to 23.5%, significantly up from 11.1% reported in Q3 2024. This led to its adjusted operating income surging 177% year-over-year to $507 million. Meanwhile, its adjusted net income soared by an impressive 473.2% year-over-year to $407 million, and its adjusted EPS of $1.90 surpassed the consensus estimates by a notable margin.
Furthermore, as per the company's projections' midpoint, Seagate's Q4 revenues are expected to come in at $2.4 billion and adjusted EPS to come in at $2.40, showcasing significant year-over-year and sequential growth. The company also remains confident in its ability to drive sustainable growth beyond 2025 on the back of solid industry fundamentals and its own positioning.
Meanwhile, Seagate has also outperformed its peer Western Digital Corporation's (WDC) 32.4% surge on a YTD basis and 1.6% dip over the past 52 weeks.
Among the 19 analysts covering the STX stock, the consensus rating is a 'Moderate Buy.' As of writing, the stock is trading above its mean price target of $125.72.
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OpenAI CEO Slams Meta's $100M Hiring Tactics as 'Copycat Strategy'
OpenAI CEO Slams Meta's $100M Hiring Tactics as 'Copycat Strategy'

Yahoo

time18 minutes ago

  • Yahoo

OpenAI CEO Slams Meta's $100M Hiring Tactics as 'Copycat Strategy'

June 18 - Meta (NASDAQ:META) has been offering signing bonuses as high as $100 million in an aggressive bid to recruit OpenAI staff, according to CEO Sam Altman. Speaking on the Uncapped podcast, Altman said the social media giant tried to recruit a lot of people from OpenAI but noted that none of the company's top talent had accepted the offers so far. He suggested Meta sees OpenAI as its main rival in artificial intelligence. Warning! GuruFocus has detected 5 Warning Sign with META. Altman criticized the strategy of handing out massive guaranteed compensation, saying it may hurt innovation and distract from actual progress. You're always going to where your competitor was, he said, adding that culture, not just cash, drives breakthroughs. The hiring push comes amid Meta's broader investment in AI. Last week, the company acquired a 49% stake in Scale AI for $14.3 billion, bringing founder Alexandr Wang and several team members into the fold. Wang is expected to lead a lab focused on "superintelligence," or AI that surpasses human capability. Meta has also brought in researchers from Google's DeepMind, including Jack Rae, as CEO Mark Zuckerberg continues to take a hands-on role in expanding the company's AI capabilities. Despite delays in rolling out its latest AI model, analysts note that Meta remains a central player in the open-source AI space, thanks to its Llama models. Experts say its investments may still yield long-term gains in model training and infrastructure. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) INVESTOR ALERT: Investors With Large Losses in Rocket Pharmaceuticals, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) INVESTOR ALERT: Investors With Large Losses in Rocket Pharmaceuticals, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Associated Press

time19 minutes ago

  • Associated Press

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) INVESTOR ALERT: Investors With Large Losses in Rocket Pharmaceuticals, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the 'Class') who purchased or acquired the securities of Rocket Pharmaceuticals, Inc. ('Rocket' or the 'Company') (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, inclusive. For more information, submit a form at Rocket Pharmaceuticals, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030. According to the lawsuit, Defendants made misrepresentations concerning the safety and clinical trial protocol for RP-A501, a drug for the treatment of Danon disease. In particular, Defendants allegedly knew that Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. Rocket also allegedly amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. If you wish to serve as lead plaintiff for the Class, you must file papers by August 11, 2025. A lead plaintiff is a representative party acting on other class members' behalf in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal's 'Plaintiffs' Hot List' thirteen times and listed in The Legal 500 for sixteen consecutive years. ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information: Peter Allocco Investor Relations Manager Bernstein Liebhard LLP (212) 951-2030 [email protected]

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DoubleVerify Holdings, Inc. (NYSE: DV)
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DoubleVerify Holdings, Inc. (NYSE: DV)

Associated Press

time19 minutes ago

  • Associated Press

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DoubleVerify Holdings, Inc. (NYSE: DV)

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of investors (the 'Class') who purchased or acquired the common stock of DoubleVerify Holdings, Inc. ('DoubleVerify' or the 'Company') (NYSE: DV) between November 10, 2023 and February 27, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers. (the 'Complaint'). Should You Join This Class Action Lawsuit? If you purchased or acquired DoubleVerify common stock, and/or would like to discuss your legal rights and options please visit DoubleVerify Holdings, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected]. According to the lawsuit, Defendants made misrepresentations concerning the effectiveness of the Company's web advertisement verification and fraud protection services, as well as the Company billing practices. If you wish to serve as lead plaintiff for the Class, you must file papers by July 21, 2025. A lead plaintiff is a representative party acting on other class members' behalf in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal's 'Plaintiffs' Hot List' thirteen times and listed in The Legal 500 for sixteen consecutive years. ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information: Peter Allocco Investor Relations Manager Bernstein Liebhard LLP (212) 951-2030 [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store